Yourgene Health PLC Director Dealing (3003Z)
January 24 2022 - 1:00AM
UK Regulatory
TIDMYGEN
RNS Number : 3003Z
Yourgene Health PLC
24 January 2022
Yourgene Health plc
("Yourgene" or the "Company")
Director Dealing
Manchester, UK - 24 January 2022: Yourgene (AIM: YGEN), a
leading international molecular diagnostics group, announces that
it was notified on 21 January 2022 that Barry Hextall, Chief
Financial Officer of the Company, purchased 52,087 shares at 11.99p
in his SIPP account and sold 1,762 shares at 11.85p from an ISA
account in his name. Both sale and purchase of shares occurred on
21 January 2022.
Following the above transactions, Barry Hextall is interested in
600,000 ordinary shares in the Company, representing approximately
0.08% of the Company's issued share capital.
This announcement contains inside information for the purposes
of the UK Market Abuse Regulation.
The Directors of the Company take responsibility for this
announcement.
Yourgene Health plc Tel: +44 (0)161 669 8122
Lyn Rees, Chief Executive Officer investors@yourgene-health.com
Barry Hextall, Chief Financial Officer
Joanne Cross, Director of Marketing
Cairn Financial Advisers LLP (NOMAD) Tel: +44 (0)20 7213 0880
Liam Murray / James Caithie / Ludovico
Lazzaretti
N+1 Singer (Joint Corporate Broker) Tel: +44 (0)20 7496 3000
Aubrey Powell / Tom Salvesen / George
Tzimas
Stifel Nicolaus Europe Limited (Joint Tel: +44 (0)20 7710 7600
Corporate Broker)
Nicholas Moore / Matthew Blawat / Ben
Maddison
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com
Relations)
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / Mob: 07584 391
303
About Yourgene Health
Yourgene Health is an international molecular diagnostics group
which develops and commercialises genetic products and services.
The group works in partnership with global leaders in DNA
technology to advance diagnostic science.
Yourgene primarily develops, manufactures, and commercialises
simple and accurate molecular diagnostic solutions, for
reproductive health, precision medicine and now infectious
diseases. The Group's flagship products include non-invasive
prenatal tests (NIPT) for Down's Syndrome and other genetic
disorders, Cystic Fibrosis screening tests, invasive rapid
aneuploidy tests, and a recent extension into the oncology space
with DPYD genotyping.
The launch of Yourgene Genomic Services has enabled Yourgene to
offer a global laboratory service network equipped to be a full
life-cycle partner for clinical, research and pharmaceutical
organisations to support partners at the preclinical, clinical, and
post-market stages to develop, manufacture, obtain regulatory
approval and commercialise new products and services. In addition,
Yourgene Genomic Services offers an NIPT and high throughput COVID
testing service.
In August 2020, Yourgene acquired Coastal Genomics , Inc., a
sample preparation technology company based in Vancouver, Canada,
enabling the Company to extend its offering and IP portfolio in the
DNA sample preparation sector. The acquisition increased Yourgene's
geographical penetration into the US and Canada, supplementing
existing coverage in the UK, Europe, MEA and Asia.
Yourgene Health is headquartered in Manchester, UK with offices
in Taipei, Singapore, the US and Canada, and is listed on the
London Stock Exchange's AIM market under the ticker "YGEN". For
more information visit www.yourgene-health.com and follow us on
twitter @Yourgene_Health.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Barry Hextall
--------------------------------------- ----------------------------------
2 Reason for the notification
---------------------------------------------------------------------------
a) Position/status Chief Financial Officer
--------------------------------------- ----------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------------------- ----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------
a) Name Yourgene Health plc
--------------------------------------- ----------------------------------
b) LEI 213800UUIT8BZE7QEH33
--------------------------------------- ----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------------
a) Description of the Ordinary shares of 0.1p each
financial instrument,
type of instrument
Identification code ISIN: GB00BN31ZD89
b) Nature of the transaction Purchase of ordinary shares
--------------------------------------- ----------------------------------
c) Price(s) and volume(s)
-------------- ---------------
Price(s) Volume(s)
-------------- ---------------
11.99p 52,087
-------------- ---------------
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 21 January 2022
--------------------------------------- ----------------------------------
f) Place of the transaction UK
--------------------------------------- ----------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Barry Hextall
--------------------------------------- ----------------------------------
2 Reason for the notification
---------------------------------------------------------------------------
a) Position/status Chief Financial Officer
--------------------------------------- ----------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------------------- ----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------
a) Name Yourgene Health plc
--------------------------------------- ----------------------------------
b) LEI 213800UUIT8BZE7QEH33
--------------------------------------- ----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------------
a) Description of the Ordinary shares of 0.1p each
financial instrument,
type of instrument
Identification code ISIN: GB00BN31ZD89
b) Nature of the transaction Sale of ordinary shares
--------------------------------------- ----------------------------------
c) Price(s) and volume(s)
-------------- ---------------
Price(s) Volume(s)
-------------- ---------------
11.85p 1,762
-------------- ---------------
d) Aggregated information N/A
- Aggregated volume
- Price
e) Date of the transaction 21 January 2022
--------------------------------------- ----------------------------------
f) Place of the transaction UK
--------------------------------------- ----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHQXLFLLFLLBBL
(END) Dow Jones Newswires
January 24, 2022 02:00 ET (07:00 GMT)
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024
